MESI-STRAT: Systems Medicine of Metabolic-Signaling Networks -A New Concept for Breast Cancer Patient Stratification.
Breast cancer is a complex disease with high prevalence in the European Union and world-wide. 75%-80 of the patients have estrogen receptor-positive (ER)-positive tumors and are treated with endocrine therapies. Endocrine therapies, which block ER-driven tumor growth, show high efficacy. Yet, a significant proportion of the patients will eventually relapse with metastatic breast
Programme: This Project is not associated with a Programme
FAIRDOMHub makes use of some necessary cookies to provide its core functionality.
Additionally, we make use of Matomo to discover how people are using FAIRDOMHub in order to help us improve the service. To opt out of this, choose the "Allow only necessary cookies" or "Allow necessary cookies and embedded content" option.
You can modify your cookie preferences at any time here,
or from the link in the footer.